| 注册
首页|期刊导航|中国食品药品监管|关于修订《医疗用毒性药品管理办法》的思考

关于修订《医疗用毒性药品管理办法》的思考

徐维兴

中国食品药品监管Issue(4):94-99,6.
中国食品药品监管Issue(4):94-99,6.DOI:10.3969/j.issn.1673-5390.2025.04.009

关于修订《医疗用毒性药品管理办法》的思考

Thoughts on Revising the Management Measures for Toxic Drugs for Medical Use

徐维兴1

作者信息

  • 1. 云南省食品药品审核查验中心
  • 折叠

摘要

Abstract

Since its promulgation over 30 years ago,the Management Measures for Toxic Drugs for Medical Use(hereinafter referred to as the Measures)has played an important role in the regulation of toxic drugs for medical purposes.However,with the rapid development of the economy and society,certain provisions in the Measures require revision and improvement to better align with current regulatory demands.This paper examines challenges encountered in the regulatory process,including the classification of toxic drugs varieties,operational protocols,and the management of various stakeholders.It puts forward suggestions for revisions aimed at enhancing the practical effectiveness of the regulation,so as to better protect and promote public health.

关键词

医疗用毒性药品/管理/修订/药品监管/品种

Key words

toxic drugs for medical use/management/revision/drug regulation/variety

分类

社会科学

引用本文复制引用

徐维兴..关于修订《医疗用毒性药品管理办法》的思考[J].中国食品药品监管,2025,(4):94-99,6.

中国食品药品监管

1673-5390

访问量0
|
下载量0
段落导航相关论文